Emergent BioSolutions Reports Third Quarter and Nine Months 2017 Financial Results; Raises Calendar Year 2017 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Emergent BioSolutions Reports Third Quarter and Nine Months 2017 Financial Results; Raises Calendar Year 2017 Guidance

Emergent BioSolutions (EBS) Tops Q3 EPS by 27c

November 2, 2017 4:45 PM EDT

Emergent BioSolutions (NYSE: EBS) reported Q3 EPS of $0.68, $0.27 better than the analyst estimate of $0.41. Revenue for the quarter came in at $149.4 million versus the consensus estimate of $124.55 million.

Full Year 2017... More